IMCR logo

Immunocore Holdings (IMCR) Operating profit

annual operating profit:

-$70.46M-$10.81M(-18.13%)
December 31, 2024

Summary

  • As of today (June 27, 2025), IMCR annual operating income is -$70.46 million, with the most recent change of -$10.81 million (-18.13%) on December 31, 2024.
  • During the last 3 years, IMCR annual operating profit has risen by +$104.13 million (+59.64%).
  • IMCR annual operating profit is now -36.27% below its all-time high of -$51.71 million, reached on December 31, 2022.

Performance

IMCR Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

quarterly operating profit:

-$3.62M+$15.84M(+81.41%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR quarterly operating income is -$3.62 million, with the most recent change of +$15.84 million (+81.41%) on March 31, 2025.
  • Over the past year, IMCR quarterly operating profit has increased by +$22.87 million (+86.35%).
  • IMCR quarterly operating profit is now -152.47% below its all-time high of $6.89 million, reached on September 30, 2022.

Performance

IMCR quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

TTM operating profit:

-$47.59M+$22.87M(+32.46%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR TTM operating income is -$47.59 million, with the most recent change of +$22.87 million (+32.46%) on March 31, 2025.
  • Over the past year, IMCR TTM operating profit has increased by +$23.86 million (+33.39%).
  • IMCR TTM operating profit is now -8.05% below its all-time high of -$44.04 million, reached on December 31, 2019.

Performance

IMCR TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

IMCR Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.1%+86.3%+33.4%
3 y3 years+59.6%+83.3%+69.5%
5 y5 years+54.6%+86.8%+33.4%

IMCR Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-36.3%+59.6%-152.5%+93.9%at high+69.5%
5 y5-year-36.3%+59.6%-152.5%+93.9%at high+73.3%
alltimeall time-36.3%+59.6%-152.5%+93.9%-8.1%+73.3%

IMCR Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$3.62M(-81.4%)
-$47.59M(-32.5%)
Dec 2024
-$70.46M(+18.1%)
-$19.45M(+128.8%)
-$70.46M(+3.5%)
Sep 2024
-
-$8.50M(-46.9%)
-$68.06M(-7.7%)
Jun 2024
-
-$16.02M(-39.5%)
-$73.70M(+3.2%)
Mar 2024
-
-$26.49M(+55.3%)
-$71.44M(+19.8%)
Dec 2023
-$59.65M(+15.4%)
-$17.05M(+20.6%)
-$59.65M(-41.6%)
Sep 2023
-
-$14.14M(+2.8%)
-$102.19M(+25.9%)
Jun 2023
-
-$13.76M(-6.4%)
-$81.15M(+7.0%)
Mar 2023
-
-$14.70M(-75.3%)
-$75.88M(-8.4%)
Dec 2022
-$51.71M
-$59.59M(-964.7%)
-$82.81M(+26.1%)
Sep 2022
-
$6.89M(-181.3%)
-$65.66M(-44.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$8.48M(-60.8%)
-$118.59M(-23.9%)
Mar 2022
-
-$21.62M(-49.1%)
-$155.88M(-12.5%)
Dec 2021
-$174.59M(+43.5%)
-$42.45M(-7.8%)
-$178.08M(+3.3%)
Sep 2021
-
-$46.04M(+0.6%)
-$172.37M(+10.2%)
Jun 2021
-
-$45.77M(+4.4%)
-$156.46M(+15.1%)
Mar 2021
-
-$43.82M(+19.3%)
-$135.92M(+13.8%)
Dec 2020
-$121.69M(-21.7%)
-$36.74M(+22.0%)
-$119.46M(-5.8%)
Sep 2020
-
-$30.13M(+19.4%)
-$126.75M(+31.2%)
Jun 2020
-
-$25.23M(-7.8%)
-$96.63M(+35.3%)
Mar 2020
-
-$27.36M(-37.9%)
-$71.40M(+62.1%)
Dec 2019
-$155.38M(+30.2%)
-$44.04M
-$44.04M
Dec 2018
-$119.37M
-
-

FAQ

  • What is Immunocore Holdings annual operating income?
  • What is the all time high annual operating profit for Immunocore Holdings?
  • What is Immunocore Holdings annual operating profit year-on-year change?
  • What is Immunocore Holdings quarterly operating income?
  • What is the all time high quarterly operating profit for Immunocore Holdings?
  • What is Immunocore Holdings quarterly operating profit year-on-year change?
  • What is Immunocore Holdings TTM operating income?
  • What is the all time high TTM operating profit for Immunocore Holdings?
  • What is Immunocore Holdings TTM operating profit year-on-year change?

What is Immunocore Holdings annual operating income?

The current annual operating profit of IMCR is -$70.46M

What is the all time high annual operating profit for Immunocore Holdings?

Immunocore Holdings all-time high annual operating income is -$51.71M

What is Immunocore Holdings annual operating profit year-on-year change?

Over the past year, IMCR annual operating income has changed by -$10.81M (-18.13%)

What is Immunocore Holdings quarterly operating income?

The current quarterly operating profit of IMCR is -$3.62M

What is the all time high quarterly operating profit for Immunocore Holdings?

Immunocore Holdings all-time high quarterly operating income is $6.89M

What is Immunocore Holdings quarterly operating profit year-on-year change?

Over the past year, IMCR quarterly operating income has changed by +$22.87M (+86.35%)

What is Immunocore Holdings TTM operating income?

The current TTM operating profit of IMCR is -$47.59M

What is the all time high TTM operating profit for Immunocore Holdings?

Immunocore Holdings all-time high TTM operating income is -$44.04M

What is Immunocore Holdings TTM operating profit year-on-year change?

Over the past year, IMCR TTM operating income has changed by +$23.86M (+33.39%)
On this page